Patents by Inventor Huai-Ping Ling
Huai-Ping Ling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7556938Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.Type: GrantFiled: October 31, 2000Date of Patent: July 7, 2009Assignees: Millennium Pharmaceuticals, Inc., WyethInventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wenqian An
-
Patent number: 7439029Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.Type: GrantFiled: March 25, 2002Date of Patent: October 21, 2008Assignees: Wyeth, Millennium Pharmaceuticals, Inc.Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wenqian An
-
Publication number: 20070186296Abstract: TNFRSF19 nucleic acids and proteins, TNFRSF19 binding partners and modulators, and methods of using the same.Type: ApplicationFiled: February 2, 2007Publication date: August 9, 2007Applicant: WyethInventors: Ying Gao, Huai-Ping Ling, Andrew Wood, Kodangattil Sreekumar
-
Patent number: 7078481Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.Type: GrantFiled: September 27, 2000Date of Patent: July 18, 2006Assignees: Wyeth, Millennium Pharmaceuticals, Inc.Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wenqian An
-
Patent number: 7041795Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.Type: GrantFiled: April 8, 2002Date of Patent: May 9, 2006Assignees: Millennium Pharmaceuticals, Inc, WyethInventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wengian An
-
Publication number: 20050277761Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.Type: ApplicationFiled: April 8, 2002Publication date: December 15, 2005Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wenqian An
-
Patent number: 6689581Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.Type: GrantFiled: July 9, 1999Date of Patent: February 10, 2004Assignees: Wyeth, Millennium Pharmaceuticals, Inc.Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wenqian An
-
Publication number: 20030119102Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.Type: ApplicationFiled: March 25, 2002Publication date: June 26, 2003Applicant: Millennium Pharmaceuticals, Inc.Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wenqian An
-
Patent number: 6369197Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.Type: GrantFiled: April 23, 1999Date of Patent: April 9, 2002Assignees: Millennium Pharmaceuticals, Inc., American Home Products Corp.Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wengian An
-
Patent number: 6361971Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.Type: GrantFiled: September 21, 1999Date of Patent: March 26, 2002Assignees: Millennium Pharmaceuticals, Inc., American Home Products CorporationInventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wenqian An